QuidelOrtho (QDEL)

• Market cap: $2.3B
• 1 day: -2.34%
• 5 days: -5.58%
• 1 month: -12.55%
• 3 months: -24.18%
• 6 months: -22.76%
• Year to date: -24.18%
• 1 year: -27.34%
• 5 years: -65.09%
• 10 years: 30.59%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

53% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 72

36% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 42

5% more funds holding

Funds holding: 259 [Q3] → 272 (+13) [Q4]

1.14% more ownership

Funds ownership: 107.83% [Q3] → 108.97% (+1.14%) [Q4]

8% more call options, than puts

Call options by funds: $13.9M | Put options by funds: $12.9M

1% less capital invested

Capital invested by funds: $3.3B [Q3] → $3.27B (-$37.7M) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 9 [Q3] → 6 (-3) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $45 32% upside
• Avg. target: $53 55% upside
• High target: $61 79% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target	79% upside $61	Outperform Maintained	13 Feb 2025
UBS John Sourbeer 33% 1-year accuracy 1 / 3 met price target	32% upside $45	Neutral Maintained	13 Feb 2025